View organization detailsHide organization details
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
Find web3 jobs at Equity Investment funded companies. Join crypto startups and blockchain projects at this funding stage.
10 open jobs
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
Genesis Molecular AI·53 minutes ago
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
Genesis Molecular AI·53 minutes ago
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
Genesis Molecular AI·53 minutes ago
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
Genesis Molecular AI·53 minutes ago
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
Genesis Molecular AI·59 minutes ago
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
Genesis Molecular AI·59 minutes ago
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
Genesis Molecular AI·59 minutes ago
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.